ACT CAPITAL MANAGEMENT, LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2022$4,064,000
+4.9%
58,300
-1.2%
5.61%
+3.5%
Q2 2022$3,874,000
-1.3%
59,0000.0%5.42%
+30.4%
Q1 2022$3,926,000
-4.9%
59,0000.0%4.15%
+39.3%
Q4 2021$4,127,000
+97.7%
59,000
+47.5%
2.98%
+175.7%
Q3 2021$2,088,000
+60.9%
40,000
+109.7%
1.08%
+62.2%
Q2 2021$1,298,00019,0750.67%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 2,003,367$232,390,57211.06%
Frazier Life Sciences Management, L.P. 988,460$114,661,3607.62%
S Squared Technology, LLC 108,215$12,552,9406.77%
Avoro Capital Advisors LLC 2,565,555$297,604,3804.64%
APIS CAPITAL ADVISORS, LLC 24,000$2,784,0003.61%
Nicholas Investment Partners, LP 355,611$41,250,8763.08%
Ghost Tree Capital, LLC 80,000$9,280,0003.05%
SILVERARC CAPITAL MANAGEMENT, LLC 71,531$8,297,5962.52%
Affinity Asset Advisors, LLC 57,500$6,670,0001.88%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 46,092$5,344,8281.80%
View complete list of KRYSTAL BIOTECH INC shareholders